Reg A+ Disclaimer

This offering is made pursuant to Regulation A under the Securities Act of 1933. An offering statement on Form 1-A relating to the securities of Cytonics Corporation has been filed with and qualified by the Securities and Exchange Commission (SEC). The information contained in this communication is for informational purposes only and is not an offer to sell nor a solicitation of an offer to buy any securities. Any such offer or solicitation will be made only by means of an offering circular. Investing in our securities involves a high degree of risk. You should carefully consider the risk factors described in our offering circular before making an investment decision. You may obtain a copy of the offering circular:https://www.sec.gov/Archives/edgar/data/1421744/000110465924120283/tm2427963d1_partiiandiii.htm. Forward-looking statements, including, but not limited to, projections or expectations of future performance, are inherently uncertain and involve risks and uncertainties. Actual results may differ materially from those set forth in such forward-looking statements. No assurances can be given that the issuer will attain its objectives or that the value of the securities will increase. We do not undertake any obligation to update or revise any forward-looking statements. The SEC and any state securities commission have not approved or disapproved these securities or passed upon the accuracy or adequacy of the offering circular. Any representation to the contrary is a criminal offense.